Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Chronic contact eczema may help hair regrowth in alopecia areata by reducing certain immune cell movement.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.